EarningsQ1 2026 Earnings Report

Relmada Therapeutics (4E2) Q1 2026 Earnings Report

0 Followers

DE:4E2 Q1 2026 EPS Results

Actual EPS-€0.19

Consensus EPS-€0.18

Beat/MissMissed by -€0.02

One Year Ago EPS-€0.51

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ1 2026

Date05/12/2026

TimeAfter Close

Conference CallTuesday, May 12, 2026

DE:4E2 Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:4E2 Q1 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.13 / -	-0.265	―
Aug 06, 2026	2026 (Q2)	-0.18 / -0.10	-0.265	63.33% (+0.17)
May 12, 2026	2026 (Q1)	-0.18 / -0.19	-0.512	62.07% (+0.32)
Mar 19, 2026	2025 (Q4)	-0.13 / -0.24	-0.547	56.45% (+0.31)
Nov 13, 2025	2025 (Q3)	-0.37 / -0.26	-0.636	58.33% (+0.37)
Aug 07, 2025	2025 (Q2)	-0.41 / -0.26	-0.521	49.15% (+0.26)
May 12, 2025	2025 (Q1)	-0.42 / -0.51	-0.636	19.44% (+0.12)
Mar 27, 2025	2024 (Q4)	-0.59 / -0.55	-0.742	26.19% (+0.19)
Nov 07, 2024	2024 (Q3)	-0.60 / -0.64	-0.644	1.37% (<+0.01)
Aug 07, 2024	2024 (Q2)	-0.73 / -0.52	-0.742	29.76% (+0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed